Fecal Microbiota Transplantation With Immune Checkpoint Inhibitors in Lung Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2028

Conditions
Metastatic Lung Cancer
Interventions
DRUG

Antibiotics

Recipients will undergo bowel preconditioning with antibiotics (Rifaximin) following randomization.

OTHER

FMT (Fecal Microbiota Transplantation)

FMT involves the transplantation of fecal bacteria from a screened donor to a recipient. This will be achieved per os in the form of a capsule containing freeze-dried stool obtained from the donor.

Trial Locations (2)

Unknown

RECRUITING

Soroka Medical Center, Beersheba

NOT_YET_RECRUITING

Rabin Medical Center, Petah Tikva

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Biotax Labs LTD

INDUSTRY

collaborator

Israel Cancer Association

OTHER

lead

Soroka University Medical Center

OTHER